OCT 19, 2017 05:55 AM PDT
Scientists Discover "Block-and-Lock" Drug to Cure HIV
WRITTEN BY: Kara Marker
3 49 2400

For the first time, researchers dare to suggest they may have found a functional cure for HIV, the viral infection that leads to AIDS: a new drug used in combination with existing antiretroviral treatment stops HIV in its tracks. The remarkable study describing this discovery was recently published in the journal Cell Reports.

Scanning electron micrograph of HIV-1 budding (in green) from cultured lymphocyte. Credit: CDC

From the Scripps Research Institute, scientists introduce a derivative of a natural compound called didehydro-Cortistatin A (dCA). The dCA derivative works by blocking a transcriptional activator called Tat in virally-infected cells. Without Tat, viruses can’t replicate. If viruses can’t replicate, they can’t cause disease.

According to study leader Susana Valente, this is the first-ever treatment approach to completely halt viral production in infected cells.

"This is the only class of drugs that stops infected cells from making viruses outright," Valente explained. "All current antivirals work later in the viral lifecycle, so only a HIV transcriptional inhibitor like dCA can stop the side effects of low-level virus production."

The new drugs works as a “Block-and-Lock” approach. It prevents latent viruses from “waking up” and causing future infection. And why combine it with existing antiretroviral drugs? "Combining dCA with anti-retroviral therapy accelerates HIV-1 suppression and prevents viral rebound after treatment interruption, even during strong cellular activation," Valente explained.

HIV is infamous for hiding in cells, remaining dormant until treatment stops, only to resurface and cause an infection even worse than before. The new drug stops the resurfacing, and in new studies applying the maximum tolerable dose of the drug, Valente sees “virtually no side effects.”

Researchers from the SRI tested the new combination therapy in a mouse model of a latent and persistent HIV infection. Mice were given one month of treatment, and latent viruses continued to be “blocked and locked” for 19 days after treatment stopped. To put things into perspective, for mice who only received antiretroviral drugs, the virus “came back to life” within a week of the drugs stopping.

"This study shows that a 'functional cure' approach can succeed in reducing residual virus in the blood during anti-retroviral treatment and limiting viral rebound during treatment interruption,” explained co-first author Cari F. Kessing.

The results Valente and her team saw were promising given the treatment was only administered for a month. But what could the benefits be when treatment continued for a longer period of time?

“The question is, how long?” Valente said. “We're studying that now."

Source: Scripps Research Institute

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 22, 2018
Infographics
MAY 22, 2018
10 Most Common Genetic Diseases
Many human diseases have a genetic component to them. There are over 6,000 genetic disorders, many of which are fatal or severely debilitating. There are over 2000 genetic tests available.
JUN 05, 2018
Cancer
JUN 05, 2018
Clinical Trial Evaluates Precision Medicine Approaches for Common and Rare Cancers
The NCI-MATCH Phase II Clinical Trial is evaluating results of cancer treatments administered based on genetic profiles determined through molecular diagnostic testing.
JUN 06, 2018
Immunology
JUN 06, 2018
Why are women more prone to autoimmunity than men?
For a long time scientists have been trying to understand why females are more likely than males to develop autoimmune diseases. From the University of Got
JUN 06, 2018
Microbiology
JUN 06, 2018
Beating Stress with Bacteria
Microbes might be useful in the treatment of mental disorders like anxiety, depression and PTSD.
JUN 08, 2018
Health & Medicine
JUN 08, 2018
Do Vitamins and Supplements Really Matter?
There are entire stores dedicated to selling vitamins and supplements. The Internet is also full of sites that tout the benefits of "Nootropics"
JUN 14, 2018
Health & Medicine
JUN 14, 2018
Beware of Hotel Room Germs
Recently the CDC came out with a study that showed nearly 1/3 of swimming-related illnesses from 2000-2014 could be traced back to pathogens found in hotel
Loading Comments...